nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—FKBP1A—Cyclosporine—focal segmental glomerulosclerosis	0.651	0.721	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0631	0.0699	CbGbCtD
Temsirolimus—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0631	0.0699	CbGbCtD
Temsirolimus—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0473	0.0524	CbGbCtD
Temsirolimus—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0308	0.0341	CbGbCtD
Temsirolimus—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.029	0.0321	CbGbCtD
Temsirolimus—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0185	0.0204	CbGbCtD
Temsirolimus—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.0483	CcSEcCtD
Temsirolimus—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.0316	CcSEcCtD
Temsirolimus—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0257	CcSEcCtD
Temsirolimus—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.0254	CcSEcCtD
Temsirolimus—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0232	CcSEcCtD
Temsirolimus—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.0225	CcSEcCtD
Temsirolimus—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0223	CcSEcCtD
Temsirolimus—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.0206	CcSEcCtD
Temsirolimus—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0202	CcSEcCtD
Temsirolimus—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.0194	CcSEcCtD
Temsirolimus—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0189	CcSEcCtD
Temsirolimus—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0186	CcSEcCtD
Temsirolimus—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0186	CcSEcCtD
Temsirolimus—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0184	CcSEcCtD
Temsirolimus—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0173	CcSEcCtD
Temsirolimus—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0165	CcSEcCtD
Temsirolimus—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0162	CcSEcCtD
Temsirolimus—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0162	CcSEcCtD
Temsirolimus—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.016	CcSEcCtD
Temsirolimus—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0158	CcSEcCtD
Temsirolimus—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0158	CcSEcCtD
Temsirolimus—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0153	CcSEcCtD
Temsirolimus—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0153	CcSEcCtD
Temsirolimus—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0139	CcSEcCtD
Temsirolimus—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0139	CcSEcCtD
Temsirolimus—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0127	CcSEcCtD
Temsirolimus—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.0122	CcSEcCtD
Temsirolimus—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0118	CcSEcCtD
Temsirolimus—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000985	0.0111	CcSEcCtD
Temsirolimus—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.00992	CcSEcCtD
Temsirolimus—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000863	0.00971	CcSEcCtD
Temsirolimus—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000833	0.00938	CcSEcCtD
Temsirolimus—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000819	0.00922	CcSEcCtD
Temsirolimus—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000814	0.00916	CcSEcCtD
Temsirolimus—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000782	0.00881	CcSEcCtD
Temsirolimus—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000761	0.00856	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000756	0.00851	CcSEcCtD
Temsirolimus—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000752	0.00846	CcSEcCtD
Temsirolimus—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000736	0.00828	CcSEcCtD
Temsirolimus—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000734	0.00826	CcSEcCtD
Temsirolimus—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.00821	CcSEcCtD
Temsirolimus—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00816	CcSEcCtD
Temsirolimus—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00816	CcSEcCtD
Temsirolimus—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.00814	CcSEcCtD
Temsirolimus—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000713	0.00803	CcSEcCtD
Temsirolimus—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000707	0.00796	CcSEcCtD
Temsirolimus—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000705	0.00794	CcSEcCtD
Temsirolimus—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000705	0.00794	CcSEcCtD
Temsirolimus—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000692	0.00778	CcSEcCtD
Temsirolimus—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000684	0.0077	CcSEcCtD
Temsirolimus—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00766	CcSEcCtD
Temsirolimus—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.00735	CcSEcCtD
Temsirolimus—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000646	0.00727	CcSEcCtD
Temsirolimus—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000643	0.00724	CcSEcCtD
Temsirolimus—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.0072	CcSEcCtD
Temsirolimus—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00718	CcSEcCtD
Temsirolimus—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000591	0.00665	CcSEcCtD
Temsirolimus—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.0066	CcSEcCtD
Temsirolimus—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.00658	CcSEcCtD
Temsirolimus—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00642	CcSEcCtD
Temsirolimus—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000567	0.00638	CcSEcCtD
Temsirolimus—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000555	0.00625	CcSEcCtD
Temsirolimus—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.0059	CcSEcCtD
Temsirolimus—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00583	CcSEcCtD
Temsirolimus—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.00571	CcSEcCtD
Temsirolimus—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000495	0.00557	CcSEcCtD
Temsirolimus—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000491	0.00553	CcSEcCtD
Temsirolimus—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.00551	CcSEcCtD
Temsirolimus—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00543	CcSEcCtD
Temsirolimus—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00543	CcSEcCtD
Temsirolimus—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00543	CcSEcCtD
Temsirolimus—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00541	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000479	0.00539	CcSEcCtD
Temsirolimus—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000463	0.00521	CcSEcCtD
Temsirolimus—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000463	0.00521	CcSEcCtD
Temsirolimus—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00517	CcSEcCtD
Temsirolimus—Tacrolimus—ALB—focal segmental glomerulosclerosis	0.000458	1	CrCbGaD
Temsirolimus—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.00511	CcSEcCtD
Temsirolimus—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.0051	CcSEcCtD
Temsirolimus—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000449	0.00506	CcSEcCtD
Temsirolimus—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.00496	CcSEcCtD
Temsirolimus—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.000438	0.149	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000422	0.00474	CcSEcCtD
Temsirolimus—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.00471	CcSEcCtD
Temsirolimus—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.00464	CcSEcCtD
Temsirolimus—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000411	0.00463	CcSEcCtD
Temsirolimus—MTOR—kidney—focal segmental glomerulosclerosis	0.000407	0.138	CbGeAlD
Temsirolimus—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.00453	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.0045	CcSEcCtD
Temsirolimus—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00449	CcSEcCtD
Temsirolimus—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00445	CcSEcCtD
Temsirolimus—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00445	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000378	0.00426	CcSEcCtD
Temsirolimus—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.000375	0.128	CbGeAlD
Temsirolimus—FKBP1A—kidney—focal segmental glomerulosclerosis	0.000366	0.125	CbGeAlD
Temsirolimus—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00412	CcSEcCtD
Temsirolimus—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000366	0.00412	CcSEcCtD
Temsirolimus—FKBP1A—cortex of kidney—focal segmental glomerulosclerosis	0.000357	0.121	CbGeAlD
Temsirolimus—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000341	0.00384	CcSEcCtD
Temsirolimus—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00374	CcSEcCtD
Temsirolimus—MTOR—EGFR-dependent Endothelin signaling events—EDN1—focal segmental glomerulosclerosis	0.000329	0.0702	CbGpPWpGaD
Temsirolimus—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000327	0.00368	CcSEcCtD
Temsirolimus—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.00356	CcSEcCtD
Temsirolimus—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.00344	CcSEcCtD
Temsirolimus—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000294	0.00331	CcSEcCtD
Temsirolimus—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000292	0.00328	CcSEcCtD
Temsirolimus—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000291	0.00328	CcSEcCtD
Temsirolimus—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00326	CcSEcCtD
Temsirolimus—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00309	CcSEcCtD
Temsirolimus—MTOR—IFN-gamma pathway—PIAS1—focal segmental glomerulosclerosis	0.000254	0.0543	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.000227	0.0484	CbGpPWpGaD
Temsirolimus—MTOR—Interferon type I signaling pathways—PIAS1—focal segmental glomerulosclerosis	0.000212	0.0452	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling—CTGF—focal segmental glomerulosclerosis	0.000201	0.0429	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000185	0.0395	CbGpPWpGaD
Temsirolimus—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000181	0.0617	CbGeAlD
Temsirolimus—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000159	0.0542	CbGeAlD
Temsirolimus—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000155	0.0528	CbGeAlD
Temsirolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFB1—focal segmental glomerulosclerosis	0.000149	0.0317	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000137	0.0293	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—SPP1—focal segmental glomerulosclerosis	0.000128	0.0273	CbGpPWpGaD
Temsirolimus—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00012	0.0407	CbGeAlD
Temsirolimus—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000118	0.04	CbGeAlD
Temsirolimus—MTOR—Regulation of Telomerase—WT1—focal segmental glomerulosclerosis	0.000116	0.0248	CbGpPWpGaD
Temsirolimus—FKBP1A—ALK1 signaling events—TGFB1—focal segmental glomerulosclerosis	0.000101	0.0215	CbGpPWpGaD
Temsirolimus—ABCB1—nephron tubule—focal segmental glomerulosclerosis	9.64e-05	0.0328	CbGeAlD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	9.31e-05	0.0199	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	9.05e-05	0.0193	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—SERPINE1—focal segmental glomerulosclerosis	8.9e-05	0.019	CbGpPWpGaD
Temsirolimus—MTOR—TSH signaling pathway—GNAQ—focal segmental glomerulosclerosis	8.61e-05	0.0184	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFB1—focal segmental glomerulosclerosis	8.54e-05	0.0182	CbGpPWpGaD
Temsirolimus—ABCB1—kidney—focal segmental glomerulosclerosis	8.47e-05	0.0288	CbGeAlD
Temsirolimus—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	8.25e-05	0.028	CbGeAlD
Temsirolimus—MTOR—Signaling by PDGF—COL4A4—focal segmental glomerulosclerosis	8.02e-05	0.0171	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	7.98e-05	0.017	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—COL4A1—focal segmental glomerulosclerosis	7.37e-05	0.0157	CbGpPWpGaD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—SERPINE1—focal segmental glomerulosclerosis	7.23e-05	0.0154	CbGpPWpGaD
Temsirolimus—MTOR—IL4-mediated signaling events—CD40LG—focal segmental glomerulosclerosis	6.94e-05	0.0148	CbGpPWpGaD
Temsirolimus—MTOR—SREBP signalling—LPL—focal segmental glomerulosclerosis	6.25e-05	0.0133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	6.22e-05	0.0133	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling—TGFB1—focal segmental glomerulosclerosis	5.79e-05	0.0124	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	5.65e-05	0.0121	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFB1—focal segmental glomerulosclerosis	5.62e-05	0.012	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—EDN1—focal segmental glomerulosclerosis	5.51e-05	0.0118	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—NOS2—focal segmental glomerulosclerosis	5.46e-05	0.0117	CbGpPWpGaD
Temsirolimus—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	5.23e-05	0.0112	CbGpPWpGaD
Temsirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—focal segmental glomerulosclerosis	5.06e-05	0.0108	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	4.58e-05	0.00977	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AGT—focal segmental glomerulosclerosis	4.57e-05	0.00975	CbGpPWpGaD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFB1—focal segmental glomerulosclerosis	4.56e-05	0.00974	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—SERPINE1—focal segmental glomerulosclerosis	4.32e-05	0.00921	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—PCNA—focal segmental glomerulosclerosis	4.16e-05	0.00887	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	3.65e-05	0.00778	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	3.53e-05	0.00754	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CD79A—focal segmental glomerulosclerosis	3.4e-05	0.00726	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	3.32e-05	0.00709	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	3.29e-05	0.00702	CbGpPWpGaD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	3.11e-05	0.00664	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	3.01e-05	0.00641	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	2.94e-05	0.00627	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	2.94e-05	0.00627	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	2.94e-05	0.00627	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	2.88e-05	0.00614	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	2.73e-05	0.00582	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—MMP9—focal segmental glomerulosclerosis	2.69e-05	0.00574	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	2.63e-05	0.00561	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	2.46e-05	0.00525	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—MYH9—focal segmental glomerulosclerosis	2.36e-05	0.00503	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	2.22e-05	0.00473	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	2.19e-05	0.00468	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	2.18e-05	0.00465	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.13e-05	0.00455	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.04e-05	0.00436	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.96e-05	0.00418	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	1.86e-05	0.00396	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIAS1—focal segmental glomerulosclerosis	1.86e-05	0.00396	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	1.84e-05	0.00392	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	1.78e-05	0.0038	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.66e-05	0.00353	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MYH9—focal segmental glomerulosclerosis	1.37e-05	0.00293	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	1.37e-05	0.00293	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.22e-05	0.0026	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.21e-05	0.00258	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	1.2e-05	0.00256	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	1.12e-05	0.00239	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.11e-05	0.00237	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	1.1e-05	0.00235	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—LPL—focal segmental glomerulosclerosis	1.09e-05	0.00233	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.02e-05	0.00217	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1e-05	0.00214	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	9.31e-06	0.00199	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.31e-06	0.00199	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS2—focal segmental glomerulosclerosis	8.54e-06	0.00182	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—focal segmental glomerulosclerosis	8.32e-06	0.00178	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.89e-06	0.00168	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.66e-06	0.00163	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.53e-06	0.00161	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.25e-06	0.00155	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SERPINE1—focal segmental glomerulosclerosis	7.19e-06	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.85e-06	0.00146	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.81e-06	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—focal segmental glomerulosclerosis	6.79e-06	0.00145	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	6.66e-06	0.00142	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.55e-06	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Disease—LPL—focal segmental glomerulosclerosis	6.15e-06	0.00131	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.05e-06	0.00129	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	5.86e-06	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.72e-06	0.00122	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.4e-06	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.24e-06	0.00112	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.04e-06	0.00107	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	4.95e-06	0.00106	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	4.82e-06	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—focal segmental glomerulosclerosis	4.8e-06	0.00103	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—focal segmental glomerulosclerosis	4.54e-06	0.000969	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.44e-06	0.000947	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.31e-06	0.000919	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	4.24e-06	0.000905	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.08e-06	0.00087	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	4.07e-06	0.000867	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SERPINE1—focal segmental glomerulosclerosis	4.05e-06	0.000863	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.91e-06	0.000833	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.86e-06	0.000823	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.68e-06	0.000786	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.63e-06	0.000775	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	3.48e-06	0.000742	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.42e-06	0.000731	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.4e-06	0.000726	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	3.2e-06	0.000683	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.18e-06	0.000679	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.11e-06	0.000663	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	3.01e-06	0.000643	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.95e-06	0.000629	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	2.94e-06	0.000627	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.83e-06	0.000604	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.78e-06	0.000593	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	2.67e-06	0.000569	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—focal segmental glomerulosclerosis	2.55e-06	0.000545	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	2.51e-06	0.000536	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	2.24e-06	0.000478	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	2.22e-06	0.000473	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.17e-06	0.000463	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	2.09e-06	0.000446	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.97e-06	0.000421	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.93e-06	0.000412	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.9e-06	0.000405	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.82e-06	0.000387	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.79e-06	0.000382	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.79e-06	0.000381	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.46e-06	0.000311	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.37e-06	0.000293	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.37e-06	0.000292	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.17e-06	0.000249	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	8.97e-07	0.000191	CbGpPWpGaD
